epidermal growth factor receptor
Showing 1 - 5 of 5
Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor Trial (pH Measurement of in vivo tissue)
Not yet recruiting
- Glioblastoma Multiforme
- +2 more
- pH Measurement of in vivo tissue
- (no location specified)
Sep 26, 2023
NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- (no location specified)
Mar 27, 2023
Recurrent Cervical Carcinoma, Radiotherapy, Epidermal Growth Factor Receptor Trial in Beijing (Combination of nimotuzumab and
Recruiting
- Recurrent Cervical Carcinoma
- +6 more
- Combination of nimotuzumab and radiotherapy
-
Beijing, Beijing, ChinaLei Li
Dec 18, 2020
Epidermal Growth Factor Receptor, NSCLC Trial in Boston (Erlotinib)
Terminated
- Epidermal Growth Factor Receptor
- Non-Small Cell Lung Cancer
-
Boston, Massachusetts
- +2 more
Nov 5, 2019
NSCLC, Epidermal Growth Factor Receptor Trial in Guangzhou (Erlotinib Hydrochloride)
Unknown status
- Non-small Cell Lung Cancer
- Epidermal Growth Factor Receptor
- Erlotinib Hydrochloride
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Mar 5, 2017